Exxon, Shell File Move for Genetic Testing of Plaintiff’s Tissue and Blood
September 16, 2013
DOCUMENTS
- Motion
GRETNA, La. –– Defendants Exxon Mobil Corp. and Shell Oil Co. are seeking access to a plaintiff’s tissue and blood, saying that genetic testing will indicate whether the plaintiff has an “inherited propensity or susceptibility” to develop his cancer.
In the Aug. 28 motion filed in Louisiana’s 24th Judicial District Court for Jefferson Parish, Exxon Mobil Corp. and Shell Oil Co. seek testing of the plaintiff’s tissue and blood, specifically from the plaintiff’s kidney, adrenal gland and lymph nodes.
The motion additionally seeks a blood sample from the plaintiffs to be taken at the office of Dr. John …
UPCOMING CONFERENCES

HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
April 08, 2025 - Long Beach, CA
The Westin Long Beach

HarrisMartin's Data Breach Litigation Conference
March 26, 2025 - Charlotte, NC
Omni Charlotte Hotel